Contract 75A50325F80003
Genentech USA, Inc · Department Of Health And Human Services · March 27, 2026
Genentech USA, Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on March 27, 2026 for $45.11 million (current value) of work in pharmaceutical preparation manufacturing. Performance is in South San Francisco, CA. This is a task or delivery order issued under parent IDIQ 36F79723D0219. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $45.11 million.
Contract details
- PIID
- 75A50325F80003
- Parent IDIQ
- 36F79723D0219
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- South San Francisco, CA
- First action
- March 27, 2026
Description
EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI TERMINATION FOR CONVENIENCE AGREEMENT AND CLOSEOUT MODIFICATION.
Modification timeline
-
March 27, 2026Mod P00002 · Other Administrative Action$45.11M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 27, 2026 | $176.14M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50325F80003?
Contract 75A50325F80003 is a federal contract awarded to Genentech USA, Inc by Department Of Health And Human Services on March 27, 2026 for $45.11 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50325F80003?
Genentech USA, Inc won contract 75A50325F80003 from Department Of Health And Human Services.
How much is contract 75A50325F80003 worth?
Contract 75A50325F80003 has obligated $0 to date but carries a potential ceiling of $45.11 million if fully funded and all options are exercised.